Fresh2 Group Ltd (FRES)

$2.11

+0.05

(+2.43%)▲

Market is closed - opens 7 PM, 29 Jul 2024

Performance

  • $2.02
    $2.30
    $2.11
    downward going graph

    4.27%

    Downside

    Day's Volatility :12.17%

    Upside

    8.26%

    downward going graph
  • $1.83
    $39.00
    $2.11
    downward going graph

    13.27%

    Downside

    52 Weeks Volatility :95.31%

    Upside

    94.59%

    downward going graph

Returns

PeriodFresh2 Group LtdIndex (Russel 2000)
3 Months
-64.4%
0.0%
6 Months
-50.95%
0.0%
1 Year
-94.76%
0.0%
3 Years
-96.02%
-20.2%

Highlights

Market Capitalization
5.0M
Book Value
$103.01
Earnings Per Share (EPS)
-72.31
Profit Margin
0.0%
Operating Margin TTM
-698.85%
Return On Assets TTM
-61.97%
Return On Equity TTM
-216.23%
Revenue TTM
17.0M
Revenue Per Share TTM
38.32
Quarterly Revenue Growth YOY
-69.89999999999999%
Gross Profit TTM
0.0
EBITDA
-115.6M
Diluted Eps TTM
-72.31
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Fresh2 Group Ltd(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Technicals Summary

Sell

Neutral

Buy

Fresh2 Group Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Fresh2 Group Ltd
Fresh2 Group Ltd
-38.69%
-50.95%
-94.76%
-96.02%
-96.02%
Moderna, Inc.
Moderna, Inc.
-1.67%
18.26%
-0.21%
-64.15%
752.69%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
-0.46%
13.21%
45.59%
84.19%
244.2%
Novo Nordisk A/s
Novo Nordisk A/s
-11.0%
18.31%
61.56%
186.46%
423.59%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.85%
14.43%
39.88%
147.45%
195.07%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Fresh2 Group Ltd
Fresh2 Group Ltd
NA
NA
NA
0.0
-2.16
-0.62
NA
103.01
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.19
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.35
31.35
1.46
44.44
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
44.28
44.28
2.36
3.43
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
16.98
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Fresh2 Group Ltd
Fresh2 Group Ltd
Buy
$5.0M
-96.02%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$45.3B
752.69%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$116.9B
244.2%
31.35
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$572.0B
423.59%
44.28
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
195.07%
31.85
39.46%

Insights on Fresh2 Group Ltd

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 6.39M → 437.0K (in $), with an average decrease of 93.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -21.91M → -31.90M (in $), with an average decrease of 45.6% per quarter

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 61.6% return, outperforming this stock by 156.4%

Company Information

Organization
Fresh2 Group Ltd
Employees
75
CEO
Mr. Haohan Xu
Industry
Miscellaneous

Discover More

FAQs